Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00111631
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 218
Post-approval studies (Phase 4)Study completedNCT01461577
What this trial is testing

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 89
Not applicableUnknownNCT05244200
What this trial is testing

Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University of Sulaimani 100
Not applicableStudy completedNCT04406402
What this trial is testing

L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols

Who this might be right for
Diabetes Mellitus, Type 2ObesityArginine+1 more
Tel-Aviv Sourasky Medical Center 243
Not applicableUnknownNCT05798637
What this trial is testing

PIPAF Platelets in the Pathogenesis of Ageing Associated Frailty

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2Alzheimer Disease
Azienda Ospedaliera di Perugia 200
Not applicableUnknownNCT03774095
What this trial is testing

Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

Who this might be right for
Type 2 Diabetes MellitusObesity
Karina Vejrum Sørensen 10
Large-scale testing (Phase 3)Study completedNCT00231530
What this trial is testing

The Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 541
Not applicableWithdrawnNCT04432337
What this trial is testing

Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery

Who this might be right for
Inflammatory ResponseExtracorporeal Circulation; ComplicationsCardiac Surgery+1 more
University Hospital Center of Martinique
Not applicableActive Not RecruitingNCT04282395
What this trial is testing

Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans

Who this might be right for
Type 2 Diabetes
University of Texas at Austin 284
Very early researchLooking for participantsNCT07298057
What this trial is testing

Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics

Who this might be right for
Periodontitis, Diabetes Mellitus Type 2
Case Western Reserve University 42
Post-approval studies (Phase 4)Study completedNCT00238472
What this trial is testing

A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 24
Not applicableLooking for participantsNCT06563401
What this trial is testing

Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Karolinska Institutet 900,000
Post-approval studies (Phase 4)Study completedNCT01426802
What this trial is testing

Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 150
Not applicableStudy completedNCT05198895
What this trial is testing

Safety and Performance of the Glyconics-SX System

Who this might be right for
Diabetes Mellitus, Type 2
Glyconics Ltd 100
Large-scale testing (Phase 3)Study completedNCT00135057
What this trial is testing

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 281
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Large-scale testing (Phase 3)Study completedNCT01932775
What this trial is testing

Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Who this might be right for
Type 2 Diabetes
Medical University of Graz 99
Early research (Phase 1)Study completedNCT00961857
What this trial is testing

Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 48
Large-scale testing (Phase 3)Study completedNCT00951119
What this trial is testing

Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients

Who this might be right for
Hypertension in Type 2 Diabetes
Medical Research Foundation, The Netherlands 48
Next Page